Related Experiment Video
Updated: Mar 2, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
16.3K
SU-E-T-170: A Viable Approach to Patient Specific QA for Spine VMAT SRS Using EPID-Based Dosimetry
Medical Physics
|May 19, 2017
Summary
This study introduces a cost-effective, real-time method for patient-specific quality assurance of volumetric modulated arc therapy (VMAT) stereotactic radiosurgery (SRS) spine treatments using electronic portal imaging device (EPID) dosimetry.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Technology
Background:
- Volumetric Modulated Arc Therapy (VMAT) involves complex multi-parameter modulations, posing significant challenges for patient-specific quality assurance (QA).
- Stereotactic Radiosurgery (SRS) for spine tumors demands precise dose delivery and rigorous QA protocols.
Purpose of the Study:
- To present a viable approach for patient-specific QA of spine VMAT SRS cases utilizing Electronic Portal Imaging Device (EPID)-based dosimetry.
- To evaluate the accuracy and feasibility of EPID dosimetry for VMAT QA in clinical practice.
Main Methods:
- Spine VMAT SRS plans were optimized using 6 MV photons on a Varian Trilogy LINAC.
- QA plans were created by maintaining MLC apertures and MU weights while resetting gantry angles.
- Absolute dose was measured in a solid water phantom using EPIDose software, converting EPID images to dose distributions.
Main Results:
- The EPID-based dosimetry method achieved a pass rate typically exceeding 95.0% for the 2%/2 mm criteria.
- Discrepancies between measured and planned doses at the isocenter were generally around ±1.0%.
- The technique accurately detected sharp dose gradients at the planning target volume (PTV)-cord interface.
Conclusions:
- EPID-based dosimetry offers a real-time, financially viable solution for VMAT QA.
- This method achieves sub-millimeter dosimetry accuracy without complex inter-diode interpolations.
- EPID-based VMAT dosimetry presents a competitive alternative to existing dosimetry technologies.

